Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00508391 · ClinicalTrials.gov registry record · Phase 2
Interventricular Delay of Lumax HF-T for Heart Failure
A Phase 2 study, sponsored by Biotronik.
- Completed
- Registry status
- Phase 2
- Development phase
- 122
- Enrollment target
NCT00508391 is a Phase 2 study that has completed, run by Biotronik. The registered enrollment target is 122 participants.
The verdict
NCT00508391, a Phase 2 study, has completed, sponsored by Biotronik.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 122 participants
- Enrollment target
Study Summary
The purpose of this study is to demonstrate that the safety and efficacy of the Lumax HF-T with optimized interventricular delay biventricular pacing (OPT) is non-inferior to the Lumax HF-T with simultaneous biventricular pacing (SIM) in patients with heart failure requiring cardiac resynchronization therapy.
Interventions
- DEVICE Optimized interventricular delay biventricular pacing
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 122 participants |
| Start Date | 2007-07 |
| Est. Completion | 2009-08 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00508391
The ClinicalTrials.gov registry entry for NCT00508391 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 122 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Biotronik, which has 30 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Optimized interventricular delay biventricular pacing is the first listed.
NCT00508391 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00508391 about?
NCT00508391 is a clinical study titled "Interventricular Delay of Lumax HF-T for Heart Failure". The purpose of this study is to demonstrate that the safety and efficacy of the Lumax HF-T with optimized interventricular delay biventricular pacing (OPT) is non-inferior to the Lumax HF-T with simultaneous biventricular pacing (SIM) in patients with heart failure requiring cardiac resynchronizatio...
What is the current status of trial NCT00508391?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 122 participants. The study started on 2007-07. Estimated completion is 2009-08.
What interventions are being tested in trial NCT00508391?
The interventions under investigation include: Optimized interventricular delay biventricular pacing (DEVICE).
Who is sponsoring clinical trial NCT00508391?
This trial is sponsored by Biotronik, which has 30 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.